Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE

Identification of unknown mutations has remained laborious, expensive, and only viable for studies of selected cases. Population-based reference ranges of rarer sequence diversity are not available. However, the research and diagnostic interpretation of sequence variants depends on such information. Additionally, this is the only way to determine prevalence of severe, moderate, and silent mutations and is also relevant to the development of screening programs. We previously described a system, meltMADGE, suitable for mutation scanning at the population level. Here we describe its application to a population-based study of MC4R (melanocortin 4 receptor) mutations, which are associated with obesity. We developed nine assays representing MC4R and examined a population sample of 1,100 subjects. Two paucimorphisms were identified (c.307G > A/ p.Val103Ile in 27 subjects and c.-178A > C in 22 subjects). Neither exhibited any anthropometric effects, whereas there would have been > 90% power to detect a body mass index (BMI) effect of 0.5 kg/m(2) at P = 0.01. Two private variants were also identified. c.335C > T/p.Thr112Met has been previously described and appears to be silent. A novel variant, c.260C > A/p.Ala87Asp, was observed in a subject with a BMI of 31.5 k g/m(2) (i.e., clinically obese) but not on direct assay of a further 3,525 subjects. This mutation was predicted to be deleterious and analysis using a cyclic AMP (cAMP) responsive luciferase reporter assay showed substantial loss of function of the mutant receptor. This population,based mutation scan of MC4R suggests that there is no severe MC4R mutation with high prevalence in the United Kingdom, but that obesity,causing MC4R mutation at 1 in 1,100 might represent one of the commonest autosomal dominant disorders in man.